Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 1861 AL 1875

Mechanistic insights into the pathogenesis of neurodegenerative diseases: towards the development of effective therapy

Nazam F, Shaikh S, Nazam N, Alshahrani AS, Hasan GM, Hassan MI.

Mol Cell Biochem. 2021 Jul;476(7):2739-2752. doi: 10.1007/s11010-021-04120-6. Epub 2021 Mar 9.

Data-driven biomarker analysis using computational omics approaches to assess neurodegenerative disease progression

Krokidis MG, Exarchos TP, Vlamos P.

Math Biosci Eng. 2021 Feb 22;18(2):1813-1832. doi: 10.3934/mbe.2021094.

Genetic testing in dementia-A medical genetics perspective

Huq AJ, Sexton A, Lacaze P, Masters CL, Storey E, Velakoulis D, James PA, Winship IM.

Int J Geriatr Psychiatry. 2021 Aug;36(8):1158-1170. doi: 10.1002/gps.5535. Epub 2021 Mar 28.

Role of triggering receptor expressed on myeloid cells 2 (TREM2) in neurodegenerative dementias

Shafi S, Singh A, Ibrahim AM, Alhajri N, Abu Izneid T, Pottoo FH.

Eur J Neurosci. 2021 May;53(10):3294-3310. doi: 10.1111/ejn.15215. Epub 2021 Apr 26.

Mural Cells: Potential Therapeutic Targets to Bridge Cardiovascular Disease and Neurodegeneration

Lin A, Peiris NJ, Dhaliwal H, Hakim M, Li W, Ganesh S, Ramaswamy Y, Patel S, Misra A.

Cells. 2021 Mar 8;10(3):593. doi: 10.3390/cells10030593.

Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development-Review

Łukasik P, Załuski M, Gutowska I.

Int J Mol Sci. 2021 Mar 13;22(6):2935. doi: 10.3390/ijms22062935.

Neuroticism and Risk of Parkinson's Disease: A Meta-Analysis

Terracciano A, Aschwanden D, Stephan Y, Cerasa A, Passamonti L, Toschi N, Sutin AR.

Mov Disord. 2021 Aug;36(8):1863-1870. doi: 10.1002/mds.28575. Epub 2021 Apr 4.

Potential of Medicinal Plants as Neuroprotective and Therapeutic Properties Against Amyloid-β-Related Toxicity, and Glutamate-Induced Excitotoxicity in Human Neural Cells

Lobine D, Sadeer N, Jugreet S, Suroowan S, Keenoo BS, Imran M, Venugopala KN, Ibrahim FM, Zengin G, Mahomoodally MF.

Curr Neuropharmacol. 2021;19(9):1416-1441. doi: 10.2174/1570159X19666210412095251.

Dementia is an age-independent risk factor for severity and death in COVID-19 inpatients

Tahira AC, Verjovski-Almeida S, Ferreira ST.

Alzheimers Dement. 2021 Nov;17(11):1818-1831. doi: 10.1002/alz.12352. Epub 2021 Apr 21.

Multimodal Imaging in a Patient With Alzheimer Disease and Parkinsonism Because of a Presenilin-1 Mutation

Lu JY, Sun YM, Yen TC, Zuo CT, Wang J.

Clin Nucl Med. 2021 Sep 1;46(9):e483-e484. doi: 10.1097/RLU.0000000000003674.

Chronic Neurological Disorders: Genetic and Epigenetic Markers for Monitoring of Pharmacotherapy

Sarangi SC, Sopory P, Reeta KH.

Neurol India. 2021 Mar-Apr;69(2):252-259. doi: 10.4103/0028-3886.314522.

Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches

Cruz-Vicente P, Passarinha LA, Silvestre S, Gallardo E.

Molecules. 2021 Apr 11;26(8):2193. doi: 10.3390/molecules26082193.

5-Lipoxygenase as an emerging target against age-related brain disorders

Yan M, Zhang S, Li C, Liu Y, Zhao J, Wang Y, Yang Y, Zhang L.

Ageing Res Rev. 2021 Aug;69:101359. doi: 10.1016/j.arr.2021.101359. Epub 2021 May 10.

Ocular biomarkers and their role in the early diagnosis of neurocognitive disorders

Chalkias IN, Tegos T, Topouzis F, Tsolaki M.

Eur J Ophthalmol. 2021 Nov;31(6):2808-2817. doi: 10.1177/11206721211016311. Epub 2021 May 17.

Association of Socioeconomic Status With Dementia Diagnosis Among Older Adults in Denmark

Petersen JD, Wehberg S, Packness A, Svensson NH, Hyldig N, Raunsgaard S, Andersen MK, Ryg J, Mercer SW, Søndergaard J, Waldorff FB.

JAMA Netw Open. 2021 May 3;4(5):e2110432. doi: 10.1001/jamanetworkopen.2021.10432.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias